Brain Injuries, TraumaticNCT05767502
Assignment of the Verbal Component Score and Addition of Pupil Reaction to the Glasgow Coma Scale
An observational study of Brain Injuries, Traumatic, run by Uludag University at 1 site in Turkey (Türkiye).
Trial summary
In this study, it is aimed to determine the prognostic value of GCS-P and the GCS-P score, which is formed by assigning a verbal score, in patients with traumatic brain injury, where all parameters can be evaluated. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Brain Injuries, Traumatic
- What is being tested?
- GCS-Pupil score
- How many people
- 199 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 20 Feb 2023to 1 Jun 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: When α: 0.05 β: 0.20 and the acceptable difference between models were selected as 10% using the G-Power program, the number of patients to be included in the study was determined as 199.
Who may be able to join
- Admitted to hospital due to traumatic brain injury,
- 18 years and older,
- who were alive at the time of admission,
- Patients whose GCS and pupil reactivity can be evaluated completely.
Who cannot join
- Younger than 18,
- Not alive at the time of admission,
- Patients whose GCS score and pupil reactivity are not correctly evaluated (facial trauma, past eye diseases or eye defects, etc.).
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site, 1 recruiting
- Recruiting
Bursa City Hospital
Bursa, 16000
BURSA CITY HOSPITAL ethics committee, ethics, 02249750000 ext. 1150, bursasehir@saglik.gov.tr
About this study
Official title: Investigation of the Effect of Assigning Verbal Component Score to Glasgow Coma Scale in Patients With Traumatic Brain Injury and Adding Pupil Reaction to Determining Mortality/Morbidity in Patients
In this study, it is aimed to determine the prognostic value of GCS-P and the GCS-P score, which is formed by assigning a verbal score, in patients with traumatic brain injury, where all parameters can be evaluated. In the model to be created, a new total score will be obtained with Motor score + Eye Response + assigned verbal Score-Pupil score and this score will be compared with GCS and GCS-Pupil score.
- Conditions
- Brain Injuries, Traumatic
- Being tested
- GCS-Pupil score
- Keywords
- GCS, GCS-Pupil score, Brain trauma, Consciousness
- Medical subject headings
- Brain Injuries, Traumatic
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
GCS-Pupil scoreDiagnostic test
Also called GCS+attributed verbal score- Pupil score
GCS+attributed verbal score- Step 1 to obtain pupillary score:
- Patients with a motor (M) and eye-opening response (E) total score between 2 and 6 are assigned a verbal score of +1
- Patients with an M+E score of 7 are assigned a verbal score of +2
- Patients with an M+E score of 8-9 are assigned a verbal score of +4
- Patients with an M+E score of 10 are assigned a verbal score of +5
GCS+attributed verbal score- Step 2 to obtain the pupillary score:
The total score is obtained by subtracting the pupil score from the score obtained in the 1st step. Pupil score is scored as follows;
- 0 points if both pupils react to light,
- 1 point if a pupil does not react to light and has anisocoria,
- 2 points if both pupils do not react to light
What is being measured
The primary outcome is the main question the study is designed to answer.
MORTALITY
Death of the patient while in the hospital
Measured: From admission to discharge, an average of 1 weeks
MORBIDTIY
Patients with a Glasgow Outcome score of 2 and 3 (Each patient can get 1-5 points from the Glasgow Outcome score. A low score indicates a negative result.
Measured: From admission to discharge, an average of 1 weeks
Secondary outcomes (2)
MORTALITY
Death within 3 months after hospital discharge
Measured: 3 months after hospital discharge
MORBIDITY
A Glaskow Coma Outcome Score of 2 and 3 at the end of 3 months after discharge from the hospital. (Each patient can get 1-5 points from the Glasgow Outcome score. A low score indicates a negative result)
Measured: 3 months after hospital discharge
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Mar 2023
- Study start20 Feb 2023
- Primary completion1 Mar 2024 (estimated)
- Study completion1 Jun 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Brain Injuries, TraumaticStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 199 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Uludag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, AKİF BULUT, Uludag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05767502
- Sponsor's protocol ID
- 2019-KAEK-140
- Status last verified
- Mar 2023
- First submitted
- 28 Feb 2023
- Last updated
- 14 Mar 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Sharing of study data is not allowed in our country.
Study at a glance
From the registry record, last updated by the sponsor on 14 Mar 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Investigation of the Effect of Assigning Verbal Component Score to Glasgow Coma Scale in Patients With Traumatic Brain Injury and Adding Pupil Reaction to Determining Mortality/Morbidity in Patients
- ClinicalTrials.gov ID
- NCT05767502
- Acronym / sponsor ID
- 2019-KAEK-140
- Conditions
- Brain Injuries, Traumatic
- Keywords
- GCS, GCS-Pupil score, Brain trauma, Consciousness
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 199 participants (estimated)
- Lead sponsor
- Uludag UniversityUniversity, hospital or other
- Study start
- 20 Feb 2023 (actual)
- Primary completion
- 1 Mar 2024 (estimated)
- Study completion
- 1 Jun 2024 (estimated)
- First posted
- 14 Mar 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In this study, it is aimed to determine the prognostic value of GCS-P and the GCS-P score, which is formed by assigning a verbal score, in patients with traumatic brain injury, where all parameters can be evaluated. In the model to be created, a new total score will be obtained with Motor score + Eye Response + assigned verbal Score-Pupil score and this score will be compared with GCS and GCS-Pupil score.
Study design
- Observational model
- Case only
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- When α: 0.05 β: 0.20 and the acceptable difference between models were selected as 10% using the G-Power program, the number of patients to be included in the study was determined as 199.
Key inclusion criteria (4 listed)
- Admitted to hospital due to traumatic brain injury,
- 18 years and older,
- who were alive at the time of admission,
- Patients whose GCS and pupil reactivity can be evaluated completely.
Key exclusion criteria (3 listed)
- Younger than 18,
- Not alive at the time of admission,
- Patients whose GCS score and pupil reactivity are not correctly evaluated (facial trauma, past eye diseases or eye defects, etc.).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| GCS-Pupil scoreAlso: GCS+attributed verbal score- Pupil scoreGCS+attributed verbal score- Step 1 to obtain pupillary score: * Patients with a motor (M) and eye-opening response (E) total score between 2 and 6 are assigned a verbal score of +1 * Patients with an M+E score of 7 are assigned a verbal score of +2 * Patients with an M+E score of 8-9 are assigned a verbal score of +4 * Patients with an M+E score of 10 are assigned a verbal score of +5 GCS+attributed verbal score- Step 2 to obtain the pupillary score: The total score is obtained by subtracting the pupil score from the score obtained in the 1st step. Pupil score is scored as follows; * 0 points if both pupils react to light, * 1 point if a pupil does not react to light and has anisocoria, * 2 points if both pupils do not react to light | Diagnostic test | – |
Primary outcome
MORTALITY
Time frame: From admission to discharge, an average of 1 weeks
Death of the patient while in the hospital
MORBIDTIY
Time frame: From admission to discharge, an average of 1 weeks
Patients with a Glasgow Outcome score of 2 and 3 (Each patient can get 1-5 points from the Glasgow Outcome score. A low score indicates a negative result.
2 secondary outcomes
MORTALITY
Time frame: 3 months after hospital discharge
MORBIDITY
Time frame: 3 months after hospital discharge
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Mar 2023.
- Individual participant dataSharing planned: No. Sharing of study data is not allowed in our country.
Related trials for Brain Injuries, Traumatic
Active, not recruitingObservational study
Transforming Research and Clinical Knowledge in Traumatic Brain Injury Epileptogenesis Project (TRACK-TBI EPI)
Traumatic Brain Injury, Post-traumatic Epilepsy
Enrolling by invitationPhase 1
Pilot Safety and Exploratory Efficacy of PSC-05 for the Treatment of Chronic Mild Traumatic Brain Injury
Mild Traumatic Brain Injury
RecruitingObservational study
Intracranial Pressure Monitoring in Moderate Traumatic Brain Injury
Moderate Traumatic Brain Injury
Not yet recruitingPhase 1
Nanopulse Laser Therapy
TBI (Traumatic Brain Injury)
RecruitingObservational study
Effect of Different Intravenous Fluids on Post-operative Chronic Subdural Hematoma Size and Recurrence
Chronic Subdural Hematoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Brain Injuries, Traumatic, run by Uludag University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 14 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
MORTALITY (time frame: From admission to discharge, an average of 1 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Mar 2023.